2013
DOI: 10.1016/j.peptides.2013.07.011
|View full text |Cite
|
Sign up to set email alerts
|

AGH is a new hemoglobin alpha-chain fragment with antinociceptive activity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
14
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 12 publications
(14 citation statements)
references
References 72 publications
0
14
0
Order By: Relevance
“…Noteworthy is that Pep5 derived from G1/S cyclin D2 of the HeLa cell cycle was capable of inducing cell death in vitro and also in vivo when tested in rat C6 glioblastoma [14]. Furthermore, in another recent report peptide AGH, a fragment of the hemoglobin alphachain, inhibited peripheral inflammatory hyperalgesic responses through indirect activation of mμ opioid receptors (MOR), indicating a potential to control inflammatory chronic pain [61].…”
Section: Discussionmentioning
confidence: 99%
“…Noteworthy is that Pep5 derived from G1/S cyclin D2 of the HeLa cell cycle was capable of inducing cell death in vitro and also in vivo when tested in rat C6 glioblastoma [14]. Furthermore, in another recent report peptide AGH, a fragment of the hemoglobin alphachain, inhibited peripheral inflammatory hyperalgesic responses through indirect activation of mμ opioid receptors (MOR), indicating a potential to control inflammatory chronic pain [61].…”
Section: Discussionmentioning
confidence: 99%
“…Nonetheless, the blood of slaughtered animals is a potential source of bioactive peptides. Indeed, few publications have reported that the blood proteins, especially HB, are potential sources of bioactive peptides . Bovine HB is a protein easily digestible by the human GI digestion process.…”
Section: Discussionmentioning
confidence: 99%
“…This particular peptide itself is a cleavage product of the hemoglobin alphachain. Subsequent validation showed that this peptide exerts an antinociceptive effect in mice (Ribeiro et al, 2013).…”
Section: Current Status Of Peptidomics In Proteolysis Studiesmentioning
confidence: 99%
“…In-depth analysis using bioinformatics will reveal differentially regulated peptides as well as revealing potential peptide biomarkers and peptide-substrate identification. (Ribeiro et al, 2013) number of the cancer biomarkers identified within the past decade from urine and other biofluids, highlighting their potential as a diagnostic biomarker in ovary, pros tate and bladder cancers (Bauca et al, 2013). In recent months, there have been persistent and intense activities in biomarker research looking for new clinical candidates, which are mainly driven by the urgent need to improve the screening and the early diagnosis of certain neurodegen erative diseases and cancers.…”
Section: Application Of Peptidomics In Biomarkers Discoverymentioning
confidence: 99%
See 1 more Smart Citation